Dataset from Refractory Overactive Bladder: Sacral Neuromodulation v. Botulinum Toxin Assessment

The purpose of this randomized, open-label, active-control trial was to compare the effectiveness of intra-detrusor botulinum toxin A (Botox A�, Allergan) versus sacral neuromodulation (InterStim�, Medtronic) for the treatment of refractory urge urinary incontinence. In addition, the study evaluated select technical attributes of the interventions as well as the effect of these two interventions on other lower urinary tract and pelvic floor symptoms.